Recall archive / FDA food enforcement
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY — FDA record F-0721-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Oct 6, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
- Reason
- cGMP Deviations
- Classification
- Class II
- Recalling firm
- ULTRAtab Laboratories, Inc.
- Quantity
- 4,250,842 tablets
- Agency-reported status
- Terminated
- Source record identifier
- F-0721-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Product Codes: M943 M943L Bulk Lots: 16K038, 18B075 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Feb 16, 2022
- Recall initiation date
- Oct 6, 2021
- Center classification date
- Feb 9, 2022
- Termination date
- Sep 1, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.